pamidronate has been researched along with Canine Diseases in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate in vitro biological activity of gemcitabine, alone and in combination with Pamidronate or carboplatin, against canine osteosarcoma (OSA) cell lines." | 7.76 | Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro. ( Bear, MD; Kulp, SK; London, CA; McMahon, MB; Pennell, ML, 2010) |
| "To determine the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells and non-neoplastic cells from dogs." | 7.73 | Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs. ( Ashton, JA; Farese, JP; Lee-Ambrose, LM; Milner, RJ; van Gilder, JM, 2005) |
| "Pamidronate is a bisphosphonate drug widely utilized in veterinary oncologic practice for the palliation of malignant osteolysis." | 3.85 | Extravasation reactions associated with the administration of pamidronate: 11 cases (2008-2013). ( Barber, LG; Clifford, CA; Correa, SS; LaDue, TA; Marker, BA; Mullin, CM; Sauerbrey, ML; Thalhofer, PL; Wood, CC, 2017) |
| "To evaluate in vitro biological activity of gemcitabine, alone and in combination with Pamidronate or carboplatin, against canine osteosarcoma (OSA) cell lines." | 3.76 | Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro. ( Bear, MD; Kulp, SK; London, CA; McMahon, MB; Pennell, ML, 2010) |
| "To determine the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells and non-neoplastic cells from dogs." | 3.73 | Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs. ( Ashton, JA; Farese, JP; Lee-Ambrose, LM; Milner, RJ; van Gilder, JM, 2005) |
| "To determine whether pamidronate disodium can reduce vitamin D3-induced hypercalcemia in dogs and whether combination treatment with calcitonin is more effective than treatment with pamidronate alone." | 3.70 | Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs. ( Braselton, WE; Chiapuzio, CL; Fitzgerald, SF; Kaneene, JB; Kruger, JM; Nachreiner, RF; Rumbeiha, WK, 1999) |
| "Pamidronate was administered once in a week before PC." | 1.35 | Percutaneous cementoplasty in the palliative, multimodal treatment of primary bone tumors of the distal aspect of the radius in four dogs. ( Böttcher, P; Florian, S; Hierholzer, J; Hildebrandt, G; Krastel, D; Oechtering, G; Vera, G; Westphalen, K, 2009) |
| "Pamidronate disodium is a potentially useful drug to reduce CCF-induced toxicosis and other causes of hypercalcemia associated with increased bone resorption in dogs." | 1.31 | Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs. ( Braselton, WE; Fitzgerald, SD; Frese, KK; Kaneene, JB; Kruger, JM; Nachreiner, R; Rumbeiha, WK, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoddinott, K | 1 |
| Oblak, ML | 2 |
| Wood, GA | 1 |
| Boston, S | 1 |
| Mutsaers, AJ | 1 |
| Kozicki, AR | 1 |
| Robat, C | 1 |
| Chun, R | 1 |
| Kurzman, ID | 1 |
| Marker, BA | 1 |
| Barber, LG | 1 |
| Clifford, CA | 1 |
| Correa, SS | 1 |
| Thalhofer, PL | 1 |
| LaDue, TA | 1 |
| Mullin, CM | 1 |
| Sauerbrey, ML | 1 |
| Wood, CC | 1 |
| Pagano, C | 1 |
| Boudreaux, B | 1 |
| Shiomitsu, K | 1 |
| Böttcher, P | 1 |
| Krastel, D | 1 |
| Hierholzer, J | 1 |
| Westphalen, K | 1 |
| Florian, S | 1 |
| Hildebrandt, G | 1 |
| Vera, G | 1 |
| Oechtering, G | 1 |
| McMahon, MB | 1 |
| Bear, MD | 1 |
| Kulp, SK | 1 |
| Pennell, ML | 1 |
| London, CA | 1 |
| Boston, SE | 1 |
| Higginson, G | 1 |
| Patten, SG | 1 |
| Monteith, GJ | 1 |
| Woods, JP | 1 |
| Ashton, JA | 1 |
| Farese, JP | 1 |
| Milner, RJ | 1 |
| Lee-Ambrose, LM | 1 |
| van Gilder, JM | 1 |
| Rumbeiha, WK | 2 |
| Kruger, JM | 2 |
| Fitzgerald, SF | 1 |
| Nachreiner, RF | 1 |
| Kaneene, JB | 2 |
| Braselton, WE | 2 |
| Chiapuzio, CL | 1 |
| Fitzgerald, SD | 1 |
| Nachreiner, R | 1 |
| Frese, KK | 1 |
1 trial available for pamidronate and Canine Diseases
| Article | Year |
|---|---|
Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
Topics: Amputation, Surgical; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 2015 |
9 other studies available for pamidronate and Canine Diseases
| Article | Year |
|---|---|
Effect of timing of bisphosphonate administration on canine osteosarcoma cells undergoing radiation therapy.
Topics: Animals; Bone Density Conservation Agents; Cell Line, Tumor; Cell Survival; Dog Diseases; Dogs; Drug | 2020 |
Extravasation reactions associated with the administration of pamidronate: 11 cases (2008-2013).
Topics: Animals; Blood Vessels; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Dog Diseas | 2017 |
SAFETY AND TOXICITY OF AN ACCELERATED COARSELY FRACTIONATED RADIATION PROTOCOL FOR TREATMENT OF APPENDICULAR OSTEOSARCOMA IN 14 DOGS: 10 GY × 2 FRACTIONS.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Combined Modality Therapy; Diphosphonates | 2016 |
Percutaneous cementoplasty in the palliative, multimodal treatment of primary bone tumors of the distal aspect of the radius in four dogs.
Topics: Animals; Bone Cements; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Dog Disease | 2009 |
Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis | 2010 |
The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Dog Disea | 2012 |
Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Diphosphonates; Dog Diseases | 2005 |
Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Blood Chemical Analysis; Calcitonin; Cholecalciferol; | 1999 |
Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs.
Topics: Animals; Anti-Inflammatory Agents; Calcium; Cholecalciferol; Creatinine; Diphosphonates; Dog Disease | 2000 |